CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-16 | Kumar Neil Chief Executive Officer | Shares withheld for taxes | −36,236 | $66.13 | $2.4M | 269,430 |
| 2026-05-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −33,544 | 100,632 | ||
| 2026-05-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −19,599 | 137,195 | ||
| 2026-05-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −11,553 | 127,092 | ||
| 2026-05-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units | −6,519 | 97,794 | ||
| 2026-05-16 | Apuli Maricel Chief Accounting Officer | Shares withheld for taxes | −4,714 | $66.13 | $312K | 129,401 |
| 2026-05-15 | Scott Randal W. Director | Option exercise 10b5-1 | +10,000 | $16.75 | $168K | 21,589 |
| 2026-05-15 | Scott Randal W. Director | Sale 10b5-1 | −6,200 | $66.69 | $413K | 15,389 |
| 2026-05-15 | Scott Randal W. Director | Sale 10b5-1 | −2,088 | $67.53 | $141K | 13,301 |
| 2026-05-15 | Scott Randal W. Director | Sale 10b5-1 | −1,512 | $68.23 | $103K | 11,789 |
| 2026-05-15 | Scott Randal W. Director | Sale 10b5-1 | −200 | $69.12 | $14K | 11,589 |
| 2026-05-15 | Scott Randal W. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −10,000 | 21,501 | ||
| 2026-05-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −13,973 | $66.65 | $931K | 561,713 |
| 2026-05-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −5,077 | $67.35 | $342K | 556,636 |
| 2026-05-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −950 | $68.35 | $65K | 555,686 |
| 2026-05-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −13,974 | $66.65 | $931K | 4,364,473 |
| 2026-05-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −5,076 | $67.35 | $342K | 4,359,397 |
| 2026-05-08 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −950 | $68.35 | $65K | 4,358,447 |
| 2026-05-07 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −11,217 | $67.50 | $757K | 584,469 |
| 2026-05-07 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −8,333 | $68.38 | $570K | 576,136 |
Page 6 of 19 · 373 trades